甘胆酸
脱氧胆酸
胆酸
胆汁酸
艾塞那肽
纳米载体
医学
材料科学
药理学
纳米技术
内科学
药物输送
2型糖尿病
糖尿病
内分泌学
作者
Ying Han,Wei Liu,Liqing Chen,Xin Xin,Qiming Wang,Xintong Zhang,Mingji Jin,Zhonggao Gao,Wei Huang
出处
期刊:Biomaterials
[Elsevier BV]
日期:2021-06-07
卷期号:275: 120944-120944
被引量:39
标识
DOI:10.1016/j.biomaterials.2021.120944
摘要
The oral administration route is popular with T2DM patients because they need convenience in lifelong medication. At present, oral Exenatide is not available on the market and therefore the relevant studies are valuable. Herein, we constructed a novel dual cholic acid-functionalized nanoparticle for oral delivery of Exenatide, which was based on the functionalized materials of deoxycholic acid-low molecular weight protamine and glycocholic acid-poly (ethylene glycol)-b-polysialic acid. The hydrophobic deoxycholic acid strengthened the nanoparticles and the hydrophilic glycolic acid targeted to specific transporter. We first condensed Exenatide-Zn2+ complex with deoxycholic acid-low molecular weight protamine to prepare nanocomplexes with ζ-potentials of +8 mV and sizes of 95 nm. Then, we used glycocholic acid-poly (ethylene glycol)-b-polysialic acid copolymers masking the positive charge of nanocomplexes to prepare nanoparticles with negative charges of -22 mV and homogeneous sizes of 140 nm. As a result, this dual cholic acid-functionalized nanoparticle demonstrated enhanced uptake and transport of Exenatide, and a special targeting to apical sodium-dependent cholic acid transporter in vitro. Moreover, in vivo studies showed that the nanoparticle effectively accumulated in distal ileum, raised the plasma concentration of Exenatide, prolonged hypoglycemic effect, reduced blood lipid levels, and lightened organ lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI